Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.
More specific conditions that are subtypes of Angiotensin Receptor Antagonists in the MeSH hierarchy.
5 drugs approved
Phase 4 trials (4)